Saanroo

Levagen®Palmitoylethanolamide (PEA)

Levagen® by Saanroo is a high-purity palmitoylethanolamide (PEA), an endogenous fatty acid amide derived from lipid sources such as egg yolk, peanuts, and soybeans. Manufactured in cGMP facilities and self-affirmed GRAS, Levagen® acts as an endocannabinoid receptor agonist supporting healthy inflammatory response, joint comfort, sleep quality, and post-exercise recovery. This stable, odorless, and tasteless compound is a clinically validated alternative to CBD, suitable for joint health, immune support, and sports recovery formulations.

Standardized to Palmitoylethanolamide content

Levagen®+Palmitoylethanolamide (PEA)

Levagen®+ by Saanroo is a cold-water dispersible palmitoylethanolamide (PEA) developed using patented LipiSperse® delivery technology. This innovation enhances bioavailability, stability, and functional versatility, allowing use in beverages, powders, capsules, and topicals. With a high active load (90%) and low excipients (10%), Levagen+® delivers consistent performance at lower dosages. Clinically studied across joint health, exercise recovery, cognitive support, sleep, immune health, and skin applications, Levagen+® provides formulators a multifunctional, GRAS, and cGMP-manufactured ingredient solution designed for diverse supplement and functional product development.

min. 90 %